Status:
COMPLETED
Inosine Energy Expenditure Study
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Healthy Volunteers
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
Investigators want to test whether the intake of the nucleoside inosine increases the human energy expenditure. Inosine occurs as a metabolic intermediate in the human body and is sometimes taken as a...
Eligibility Criteria
Inclusion
- Healthy male volunteers
- BMI between 18-27 kg/m2
- Age between 18 and 40 years
Exclusion
- Chronic concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, diabetes mellitus),
- Known or suspected non-compliance, drug or alcohol abuse,
- Inability to follow the procedures of the study
- Participation in another study with investigational drug within the 30 days preceding and during the present study,
- Previous enrolment into the current study,
- Enrolment of the investigator, his/her family members, employees and other dependent persons,
- Thyroid disorders
Key Trial Info
Start Date :
February 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04476238
Start Date
February 28 2022
End Date
April 30 2023
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel, Department of Endocrinology
Basel, Canton of Basel-City, Switzerland, 4031